REAL WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN CROHN’S DISEASE WHEN USED AS A FIRST BIOLOGIC OR AFTER FAILURE OF ONE PREVIOUS ANTI-TNF (EVOLVE-IB STUDY)

Fernando Muñoz  1     Cristina Rodriguez  2     Javier Pérez Gisbert  3     Claudia Herrera de Guise  4     Isabel Vera Mendoza  5     Ana Gutierrez Casbas  6     María Dolores Martín-Arranz  7     Pilar Martínez-Montiel     Vanesa Royo     Patricia Suárez     Esther García-Planella     Orlando Garcia-Bosch     Marisa Iborra     Jesus Aparicio     Ignacio Tagarro     Alonso Fernandez-Nista    
1 Complejo Asistencial Universitario de Salamanca,Salamanca,Spain
2 Complejo Hospitalario de Navarra,Pamplona,Spain
3 Hospital Universitario de La Princesa,Madrid,Spain
4 Hospital Universitario Vall d'Hebron,Barcelona,Spain
5 Hospital Puerta de Hierro Majadahonda,Madrid,Spain
6 Hospital General Universitario de Alicante,Alicante,Spain
7 La P

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing